Skip to main content

View full-text article in PMC

. 2020 Jan;61(1):51–57. doi: 10.2967/jnumed.119.229187

TABLE 3.

Number and Percentage of Lesions Rated as Malignant on ¹⁸F-PSMA-1007 PET and ⁶⁸Ga-PSMA-11 PET According to Their Origin

	⁶⁸Ga-PSMA-11 PET		¹⁸F-PSMA-1007 PET
Parameter	Patients	Lesions	Patients	Lesions
Total patients	82/102 (80.4%)	126	82/102 (80.4%)	124
Local recurrence	33/102 (32.4%)	33/126 (26.2%)	27/102 (26.5%)	27/124 (21.8%)
LN metastasis	51/102 (50.0%)	64/126 (50.8%)	55/102 (53.9%)	70/124 (56.5%)
Abdominopelvic		43		36
Supradiaphragmatic		21		34
Bone metastases	26/102 (25.5%)	26/126 (20.6%)	22/102 (21.6%)	22/124 (17.7%)
Other metastases	3/102 (2.9%)	3/126 (2.3%)	5/102 (4.9%)	5/124 (4.0%)